XEN® stent complications: a case series
Abstract Background XEN® gel stent (Allergan, Dublin/Republic of Ireland) is a relatively new microinvasive glaucoma device providing an ab-interno approach to the subconjunctival space for aqueous drainage and reduction of intraocular pressure. It is thought to be less invasive, reduce surgical tim...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2019-12-01
|
| Серии: | BMC Ophthalmology |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12886-019-1267-y |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|